Problem statement: Answer the multiple-choice question.
Query: Which drug has a 2.384% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
(a) Cn1c(N)c(C(=O)Nc2ccccc2F)sc1=S
(b) COc1cc(CN2CCCC(C(=O)c3sccc3C)C2)cc(Cl)c1O
(c) CCCNC(=O)Cc1c(OC)ccc2cc(Br)ccc12
(d) Cc1c(NC(=O)c2ccccc2F)c(=O)n(-c2ccccc2)n1C
Answer: a. Cn1c(N)c(C(=O)Nc2ccccc2F)sc1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cn1c(N)c(C(=O)Nc2ccccc2F)sc1=S
Cn1c(N)c(C(=O)Nc2ccccc2F)sc1=S
4-amino-N-(2-fluorophenyl)-3-methyl-2-sulfanylidene-1,3-thiazole-5-carboxamide